$0.10
▼ $0.00 (-2.9%)
LIMN
Liminatus Pharma, Inc.
Health Care
Investor Score
40D
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
23
Technical
53
Fundamental
38
Growth
38
Fair Value
50
News
55
Quality
40
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.